Working Group on Pediatric Gene Therapy & Medical Ethics
The mission of the Working Group on Pediatric Gene Therapy and Medical Ethics (PGTME) is to advance research, policy, and education regarding ethical issues surrounding pediatric gene therapy trials. We seek to promote improved understanding of challenges and nascent best practices for ethical research across the evolving landscape of genetic technologies.
Our group is part of NYU Langone’s Division of Medical Ethics. The group formed in 2019 to identify and address emerging ethical issues surrounding investigational gene-based therapies in pediatric populations including issues related to research design, patient autonomy, sibling and family involvement, fairness in access, and the quality of information patients and families receive.
Please see our annual report and contributions to peer-reviewed and other reputable publications and media outlets, and learn more about our Lived Experiences Subgroup.
We leverage input from stakeholder communities and our members—experts from the fields of bioethics, clinical trial design, industry, law, medicine, and patient advocacy.
Our group is funded by a gift from Parent Project Muscular Dystrophy.
For general inquiries, or to join our mailing list for quarterly updates, please contact Cara Hunt at email@example.com.